Tissue Regenix Group PLC (AIM:TRX) has successfully dispatched its first order of allograft products to the EU following approval from the Irish Health Products Regulatory Authority (HPRA).
This milestone comes alongside the announcement of new distributor agreements for Turkey and Ireland, signalling a broadening of the company's market reach.
"At our interims we outlined our intention to more broadly distribute allograft tissue products, and I am pleased to report the positive progress we are making against this growth pillar," said CEO Daniel Lee.
"These new distributor contracts, alongside the first shipment of products from our Irish logistics hub, are a great step forward in the company's EU expansion plan into markets where we gain approvals and demonstrate the effectiveness of our ongoing 4S strategy as we scale the business outside of the US."
Shipments will originate from the company's third-party logistics hub, Biostór Ireland.